← Leaderboards
Robert Benjamin Levy
University Of Miami School Of Medicine
$11,045,297
Attributed
$14,813,544
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2006–25$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,813,544 · 7
By mechanism
R01$14,688,193 · 6
P50$125,351 · 1
Top collaborators
- Victor L Perez18 shared
Most similar at University Of Miami School Of Medicine
Same institution · by research overlap
- Victor L Perez$8,283,705
- Kermit L. Carraway$5,389,186
- Karl Goodkin$8,061,198
- Norma Sue Kenyon$9,767,138
- Scheffer C G Tseng$11,372,554
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsT-LymphocyteImmuneAntigensKineticsChimeric ProteinsPathway InteractionsAllogenicIn VivoCd8b1 GeneHematopoieticEffector CellMediatingInterleukin-2TissuesPreventOrganSurvival RateVisionCytokineInflammatoryHematopoietic Stem Cell TransplantationTransgenic OrganismsRegulation
Grant awards (40)
Local regulation and deletion of T cells to induce tolerance and establish long-term survival of high-risk corneal transplants$672,170
R01 · FY2025 · EY · contact PI
Immune Mechanisms in Ocular Graft versus Host Disease$410,020
R01 · FY2025 · EY
Immune Mechanisms in Ocular Graft versus Host Disease$410,000
R01 · FY2024 · EY
Local regulation and deletion of T cells to induce tolerance and establish long-term survival of high-risk corneal transplants$410,000
R01 · FY2023 · EY · contact PI
Immune Mechanisms in Ocular Graft versus Host Disease$410,000
R01 · FY2023 · EY
Local regulation and deletion of T cells to induce tolerance and establish long-term survival of high-risk corneal transplants$68,450
R01 · FY2023 · EY · contact PI
Immune Mechanisms in Ocular Graft versus Host Disease$397,697
R01 · FY2022 · EY
Local regulation and deletion of T cells to induce tolerance and establish long-term survival of high-risk corneal transplants$397,393
R01 · FY2022 · EY · contact PI
Local regulation and deletion of T cells to induce tolerance and establish long-term survival of high-risk corneal transplants$44,785
R01 · FY2022 · EY · contact PI
Immune Mechanisms in Ocular Graft versus Host Disease$410,000
R01 · FY2021 · EY
Local regulation and deletion of T cells to induce tolerance and establish long-term survival of high-risk corneal transplants$397,443
R01 · FY2021 · EY · contact PI
Local regulation and deletion of T cells to induce tolerance and establish long-term survival of high-risk corneal transplants$410,000
R01 · FY2020 · EY · contact PI
Immune Mechanisms in Ocular Graft versus Host Disease$450,227
R01 · FY2018 · EY
Immune Mechanisms in Ocular Graft versus Host Disease$575,657
R01 · FY2017 · EY · contact PI
Immune Mechanisms in Ocular Graft versus Host Disease$682,870
R01 · FY2016 · EY
Immune Mechanisms in Ocular Graft versus Host Disease$681,732
R01 · FY2015 · EY
Immune Mechanisms in Ocular Graft versus Host Disease$613,998
R01 · FY2014 · EY
Immune Mechanisms in Ocular Graft versus Host Disease$94,053
R01 · FY2014 · EY
Allogeneic MiHA Induced Marrow Allograft Resistance$438,458
R01 · FY2010 · AI · contact PI
Memory CD8 T Cell Survival and Function Following Experimental BMT$316,661
R01 · FY2010 · CA · contact PI
Allogeneic MiHA Induced Marrow Allograft Resistance$481,572
R01 · FY2009 · AI · contact PI
Memory CD8 T Cell Survival and Function Following Experimental BMT$310,427
R01 · FY2009 · CA · contact PI
Allogeneic MiHA Induced Marrow Allograft Resistance$417,462
R01 · FY2008 · AI · contact PI
Memory CD8 T Cell Survival and Function Following Experimental BMT$301,357
R01 · FY2008 · CA · contact PI
Allogeneic MiHA Induced Marrow Allograft Resistance$413,155
R01 · FY2007 · AI · contact PI
Memory CD8 T Cell Survival and Function Following Experimental BMT$298,106
R01 · FY2007 · CA · contact PI
Allogeneic MiHA Induced Marrow Allograft Resistance$411,863
R01 · FY2006 · AI · contact PI
Memory CD8 T Cell Survival and Function Following Experimental BMT$296,829
R01 · FY2006 · CA · contact PI
ALLOGENEIC MIHA INDUCED MARROW ALLOGRAFT RESISTANCE$340,875
R01 · FY2004 · AI
ANIMAL MODEL TO STUDY THE ROLE OF CYTOTOXICITY IN GVHD$338,899
R01 · FY2004 · RR
Core--Administrative$125,351
P50 · FY2004 · HL
ALLOGENEIC MIHA INDUCED MARROW ALLOGRAFT RESISTANCE$340,875
R01 · FY2003 · AI
ANIMAL MODEL TO STUDY THE ROLE OF CYTOTOXICITY IN GVHD$338,957
R01 · FY2003 · RR
ALLOGENEIC MIHA INDUCED MARROW ALLOGRAFT RESISTANCE$340,875
R01 · FY2002 · AI
ANIMAL MODEL TO STUDY THE ROLE OF CYTOTOXICITY IN GVHD$339,013
R01 · FY2002 · RR
ANIMAL MODEL TO STUDY THE ROLE OF CYTOTOXICITY IN GVHD$335,745
R01 · FY2001 · RR
ALLOGENEIC MIHA INDUCED MARROW ALLOGRAFT RESISTANCE$327,013
R01 · FY2001 · AI
ANIMAL MODEL FOR VIRAL INDUCED BMT COMPLICATIONS$220,037
R01 · FY2001 · HL
ANIMAL MODEL TO STUDY THE ROLE OF CYTOTOXICITY IN GVHD$329,892
R01 · FY2000 · RR
ANIMAL MODEL FOR VIRAL INDUCED BMT COMPLICATIONS$213,627
R01 · FY2000 · HL